In contrast, low expression levels of ALB and STAT3 were linked to unfavorable outcomes (p < 0.05), emphasizing the complex role of these proteins in HCC pathogenesis and their potential utility in patient-personalized treatment strategies (Figure 5D). This evidence concerns the gene ALB and hepatocellular carcinoma.